Triflusal Triflusal Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren, Grendis, Aflen and Triflux. Triflusal is a selective platelet antiaggregant through; Triflusal is indicated for; In the 2008 guidelines for stroke management from the European Stroke Organization, triflusal was for the first time recommended as lone therapy, as an alternative to acetylsalicylic acid
Birch bark manuscript In Indian sculpture, a Birch bark manuscript is easily identified by the droop. A palm leaf manuscript is stiff. On July 26, 1951, during excavations in Novgorod, a Soviet expedition led by Artemiy Artsikhovsky found the first Russian birch bark writing in a layer dated to c. 1400. Since then, more than 1,000 similar documents were discovered in Staraya Russa, Smolensk, Torzhok, Pskov, Tver, Moscow, Ryazan, and Vologda, although Novgorod remains by far the most prolific source of them. In Ukraine, birch bark documents were found in Zvenyhorod, Volynia. In Belarus, several documents were unearthed in Vitebsk and Mstislavl. The